Tuberculosis Vaccine Study Shows Promise
A dangerous infectious disease that attacks the lungs is tuberculosis (TB). Mycobacterium tuberculosis is the bacteria that causes it. When an infected individual coughs, sneezes, or speaks, the disease is transferred through the air. Even those without symptoms can contract the infection by breathing in contaminated air.Thank you for reading this post, don't forget to subscribe!
Tuberculosis Vaccine Study Shows Promise : The World Health Organisation (WHO) reports that tuberculosis (TB) is the most common infectious agent-related cause of mortality, surpassing both HIV/AIDS and malaria. 10.6 million cases of tuberculosis were reported in 2021, with 1.6 million deaths attributed to the illness.
Table of Contents
Researchers are striving to create new vaccinations that can either prevent or treat tuberculosis, despite the fact that there isn’t already an effective vaccine against the illness. The Bacille Calmette-Guérin (BCG) vaccine is one interesting potential vaccination.
Tuberculosis Vaccine Study Shows Promise : Although there is just one TB vaccine available, the BCG vaccine is not commonly administered in Western Europe and the United States because to the low prevalence of TB in these locations. But in other parts of the world, the BCG vaccination is extensively used, and it works well to prevent severe forms of tuberculosis, like meningitis and miliary TB.
Baylor College of Medicine in Houston, Texas is presently doing a new research study on a vaccination against tuberculosis. The purpose of the study is to determine if travellers exposed to TB in nations with high TB infection rates can avoid contracting the disease by getting the BCG vaccine.
Tuberculosis Vaccine Study Shows Promise: Volunteers are needed for the study, according to the researchers. Participants must be HIV negative, in excellent health, and between the ages of 18 and 65 in order to be eligible. Additionally, participants must not have previously gotten the BCG vaccination and must have plans to travel for at least four weeks to two and a half years to a nation where tuberculosis is endemic.
Please visit the Baylor College of Medicine website or send an email to [email protected] if you are interested in taking part in the study.
Why ought you to think about taking part in this research?
Tuberculosis Vaccine Study Shows Promise : The BCG vaccination is not commonly administered in the US and Western Europe, and there is presently no effective vaccine to prevent tuberculosis.
This research may contribute to the creation of a novel vaccine that shields visitors from contracting tuberculosis when they visit nations where the illness is more prevalent.
Participants’ time and travel costs will be reimbursed.
Please get in touch with the study coordinator as soon as possible if you are qualified for and eager to take part in this study.
An important development in the fight against tuberculosis is the Baylor College of Medicine’s research study on the vaccine. Please get in touch with the study coordinator right once if you are qualified for and eager to take part in the study.